Oral Levofloxacin Enables Safe IV‑to‑Oral Switch and Outpatient Management

IV‑to‑Oral Transition

• In clinically stable patients, switching from intravenous to oral levofloxacin does not reduce drug exposure and maintains therapeutic effectiveness, supporting seamless route interchangeability【1】【2】.

Oral Therapy for Bacteremia

• Oral levofloxacin has been shown to effectively treat patients with bacteremia, providing comparable outcomes to intravenous therapy【2】.

Outpatient Treatment of Moderately Severe Illness

• The high oral bioavailability permits selected patients with moderately severe infections to receive complete treatment as outpatients, avoiding the need for inpatient intravenous therapy【2】.

Early Hospital Discharge Advantage

• The excellent oral bioavailability of levofloxacin offers a clinical advantage by allowing flexible dosing strategies and facilitating early hospital discharge with oral therapy【2】.

Bioavailability and Pharmacokinetics of Levofloxacin

Clinical Implications and Interactions

• Total drug exposure is equivalent between intravenous and oral formulations at the same milligram-per-kilogram dose 3
• Antacids and medications containing divalent cations (aluminum, magnesium, calcium, iron) markedly decrease levofloxacin absorption and must not be administered within 2 hours of levofloxacin, as recommended by the Centers for Disease Control and Prevention, based on guidelines from MMWR Recommendations and Reports 4